Shire acquired Baxalta on June 3, 2016. Following this date, this page will no longer be actively monitored. There will be no updates or responses posted on this page. For continued news and updates, we encourage you to follow Shire on LinkedIn at https://www.linkedin.com/company/shire
| Website | http://www.baxalta.com |
| Revenue | $10.6 billion |
| Employees | 471 (273 on RocketReach) |
| Founded | 2015 |
| Address | 1200 Lakeside Dr, Deerfield, Illinois 60015, US |
| Phone | (224) 940-2000 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+115 more
(view full list)
|
| Industry | Biotechnology, Drug Manufacturing & Research, Biopharmaceuticals, Pharmaceuticals, Healthcare |
| Keywords | Biotechnology, Therapeutics, Pharmaceutical, Rare Diseases, Hematology, Immunology, Biologics, Drug Development, Clinical Trials, Genetic Disorders, Protein Therapeutics, Oncology, Treatment, Healthcare, Health, Innovation, Research |
| Competitors | Roche, CSL Behring, Amgen, Novo Nordisk, Biogen, Grifols, Shire, Octapharma, Kedrion Biopharma, Hematogenix +41 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325412 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Baxalta employee's phone or email?
The Baxalta annual revenue was $10.6 billion in 2026.
Kjell-Åke Nilsson is the CEO of Baxalta.
273 people are employed at Baxalta.
Baxalta is based in Deerfield, Illinois.
The NAICS codes for Baxalta are [3254, 325412, 32541, 32, 325].
The SIC codes for Baxalta are [28, 283].